Premium
Clinical performance of the Prostate Health Index ( PHI ) for the prediction of prostate cancer in obese men: data from the PROMEtheuS project, a multicentre E uropean prospective study
Author(s) -
Abrate Alberto,
Lazzeri Massimo,
Lughezzani Giovanni,
Buffi Nicolòmaria,
Bini Vittorio,
Haese Alexander,
Taille Alexandre,
McNicholas Thomas,
Redorta Joan Palou,
Gadda Giulio M.,
Lista Giuliana,
Kinzikeeva Ella,
Fossati Nicola,
Larcher Alessandro,
Dell'Oglio Paolo,
Mistretta Francesco,
Freschi Massimo,
Guazzoni Giorgio
Publication year - 2015
Publication title -
bju international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 1464-4096
DOI - 10.1111/bju.12907
Subject(s) - prostate cancer , medicine , body mass index , prostate , prostate biopsy , logistic regression , prostate specific antigen , overweight , urology , cancer , gynecology , oncology
To test serum prostate-specific antigen (PSA) isoform [-2]proPSA (p2PSA), p2PSA/free PSA (%p2PSA) and Prostate Health Index (PHI) accuracy in predicting prostate cancer in obese men and to test whether PHI is more accurate than PSA in predicting prostate cancer in obese patients.